NCT01509079View on ClinicalTrials.gov

Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

PHASE2CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

March 31, 2015

Conditions
Muscle PainJoint Pain
Interventions
DRUG

Vitamin D3

Cholecalciferol capsule, 4000IU, daily for 6 months

DRUG

Vitamin D3

cholecalciferol capsule, 600 IU, daily for 6 months

Trial Locations (1)

55416

Park Nicollet Frauenshuh Cancer Center, Minneapolis

All Listed Sponsors
collaborator

University of Minnesota

OTHER

collaborator

University of Southern California

OTHER

lead

HealthPartners Institute

OTHER

NCT01509079 - Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors | Biotech Hunter | Biotech Hunter